"Shift Toward Personalized Ocular Therapies"
- The Asia-Pacific market is increasingly focused on personalized care strategies in DES management. Innovations in drug-delivery such as nanodrops, biodegradable punctal plugs, and gene-targeted anti-inflammatory therapies are advancing treatment precision.
- Moreover, companies are developing AI-driven diagnostic platforms and digital apps for real-time symptom tracking. Wearable blink sensors and environmental exposure monitors are also entering the market to offer holistic treatment insights. • This trend is especially prominent in urban markets of South Korea, Japan, and Singapore, where demand for premium and tech-integrated dry eye solutions is rising.
